The FDA approved the first pill for postpartum depression on Friday. The drug is called zuranolone, and unlike other antidepressants, it's specifically designated for postpartum depression, a condition that affects around 1 in 7 new mothers.
The big picture: Zuranolone is taken daily for two weeks. Clinical trials showed that the drug could ease depression in as little as three days.
Guests: Axios' Felix Salmon, Arielle Dreher and Marina Franco.
Credits: Axios Today is produced by Erica Pandey, Alexandra Botti, Fonda Mwangi, Robin Linn and Alex Sugiura. Music is composed by Evan Viola. You can reach us at podcasts@axios.com. You can text questions, comments and story ideas to Niala as a text or voice memo to 202-918-4893.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Ed Yong: Birding for a fulfilled life
Steve Young: What private equity could do for the NFL
Fei-Fei Li: AI's new possibilities for robots
Rep. Miller-Meeks: The GOP can lead on climate change
Sue Bird: "Society finally caught up" with women's basketball
Avril Benoît: Is ignoring humanitarian law the new norm?
Duncan McIntyre: Electrifying school bus fleets
Anna Hehir: Banning the most dangerous autonomous weapons
Alondra Nelson: AI chatbots get elections info wrong
Sen. Joe Manchin: What's at stake when we lose the center
Lee Saunders: Flexing union muscle
Dr. Sara Naseri: Menstrual blood as a diagnostic tool
Sharif El-Mekki: Building the Black teacher pipeline
Victor Pickard: A new business model for journalism
Helen Fisher: How we choose who we love
Kristin Kobes Du Mez: Inside the Evangelical MAGA vote
Sean Daniels: Using humor on stage to combat addiction
Songyee Yoon: Transforming gaming using responsible AI
Fawn Sharp: The world needs Indigenous leaders
Noah Feldman: Cracks in the Constitution
Create your
podcast in
minutes
It is Free